AzTrials
AzTrials

Health Care UtilizationNCT04778761

ACP Video Intervention for Patients With Life-Limiting Illness

A study testing Home ACP Video in people with Health Care Utilization and End Stage Disease, run by Massachusetts General Hospital at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The goal of this research is to increase patients' knowledge about advance care planning (ACP) discussions and hospice care for patients with serious illness receiving home-based care. Read more about this study

Who is it for?
Ages 21 years and older
Conditions the study is for
Health Care Utilization, End Stage Disease
What is being tested?
Home ACP Video
Could I receive a placebo?
No, everyone receives an active treatment
How many people
500 participants
Where
1 siteUnited States
Study dates
1 Apr 2021to 1 Mar 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Aged 21 or over
  • Have a one-year prognosis or less as determined by Clover Health's validated algorithm
  • Speak either English or one of the other 25 languages in which the video intervention is available

Who cannot join

  • Visually impaired beyond 20/200 corrected
  • Acute psychiatric illness or other comorbid condition that impairs cognitive ability to participate in advance care planning discussion as determined by the primary House Call Provider.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Clover Health

    Jersey City, New Jersey, 07302

Other trials in United States

About this study

Official title: Randomized Trial of a Home-Advance Care Planning Video Intervention for Patients With Life-Limiting Illness

The goal of this research is to increase patients' knowledge about advance care planning (ACP) discussions and hospice care for patients with serious illness receiving home-based care.

Read the detailed description

ACP is a process that allows patients to communicate their wishes and preferences or medical care, when they are seriously ill, to their medical providers. The study investigators would like to assess whether a home-ACP video can improve patient-clinician communication about patients wishes for their medical care and lead to more patient-centered care.

This study is a randomized clinical trial of a Home-ACP intervention among 500 adult patients with serious illness receiving medical care at home with the Clover Health House Calls Program. Study participants will be assigned to one of two groups. In one group, participants will continue to receive usual care with their home-based care team. In the second group, participants will continue to receive their usual care with their home-based care team and also view an ACP video that helps them understand ACP and provides education about ACP and hospice care.

Being tested
Home ACP Video
Medical subject headings
Patient Acceptance of Health Care

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Home ACP VideoBehavioural

    A video focused on Advance Care Planning and Hospice for patients with serious illness

Study groups in NCT04778761
Study groupRoleWhat they receive
Usual CareNo interventionUsual care entails receiving usual medical care by the home-based care team.
Video interventionExperimentalIn addition to usual care, the intervention will entail having a visit by a trained study clinician to provide access to the ACP video. The study clinician will discuss the content of the video and answer any questions.
Receives: Behavioral: Home ACP Video

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hospice utilization

    Compare the use of hospice (yes vs. no) between the study groups

    Measured: up to one year follow-up or death

Secondary outcomes (8)
  1. Hospice length of stay

    Compare hospice length-of-stay between the study groups

    Measured: up to one year follow-up or death

  2. Rates of documented resuscitation preferences in the Electronic Health Record

    Compare documented resuscitation preferences in the Electronic Health Record between the two groups

    Measured: up to one year follow-up or death

  3. Rates of Advance Care Planning documentation in the Electronic Health Record

    Compare advance care planning documentation in the Electronic Health Record between the two groups

    Measured: up to one year follow-up or death

  4. Patient knowledge about Advance Care Planning

    Compare patient's knowledge about advance care planning using a 5-item knowledge questionnaire (range 0-5), higher score indicate more knowledge

    Measured: Up to two days following the intervention visit

  5. Patient reported confidence in care

    Compare patient's reported confidence in their medical care using a single Likert response question between the two study groups. Score range from 0-4. Higher scores indicate higher confidence in care

    Measured: up to two days following the intervention visit

  6. Patient reported satisfaction with clinician communication

    Compare patient satisfaction with their communication with their clinician using the CAHPS subscale. Score range 0-20. Higher score indicate better satisfaction with communication

    Measured: up to two days following the intervention visit

  7. Patient reported decisional satisfaction

    Compare patient reported decisional satisfaction between the study groups using the Satisfaction with Decision Scale. Scale range from 6-30. Higher scores indicate higher satisfaction with decision

    Measured: up to two days following the intervention visit

  8. Patient reported decisional certainty

    Compare patient reported decisional certainty between the two groups using the Decision Conflict Scale. Score ranges from 0 to 100. Higher scores indicate higher decisional conflict

    Measured: up to two days following the intervention visit

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Mar 2021
  2. Study start1 Apr 2021
  3. Primary completion1 Mar 2027 (estimated)
  4. Study completion1 Mar 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04778761
Sponsor's protocol ID
2020P001277
Status last verified
Oct 2026
First submitted
4 Feb 2021
Last updated
27 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Home ACP Video in people with Health Care Utilization and End Stage Disease, run by Massachusetts General Hospital at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 27 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hospice utilization (time frame: up to one year follow-up or death). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in